Latest press releases
Filter by topic
- All
- Corporate
- Advanced Wound Care
- Continence Care
- Infusion Care
- Ostomy Care
- Our People
- Communities
- Financial Performance
Filter by year
12-May-22
AGM trading update for the four months ended 30 April 2022
09-May-22
Convatec invests in BlueWind Medical to fund development of innovative neuromodulation technology
14-Mar-22
Convatec Group completes acquisition of Triad Life Sciences Inc as it enters attractive wound biologics segment1
08-Mar-22
Annual Results for the twelve months ended 31 December 2021
28-Feb-22
Non-Executive Directors - Appointment and Resignation
28-Jan-22
Entry into the attractive wound biologics segment through the acquisition of Triad Life Sciences Inc
27-Jan-22
Board Committee Changes
09-Dec-21
Chief Financial Officer succession
29-Oct-21
Trading update for the three months ended 30 September 2021
01-Oct-21
Convatec Group Plc Announces Pricing of $500 Million 3.875% Senior Notes due 2029
30-Sep-21
Convatec Group Plc Announces Offering of $500 Million Senior Notes due 2029
30-Jul-21
Interim Results for the six months ended 30 June 2021
29-Apr-21
Trading update for the three months ended 31 March 2021
05-Mar-21
Annual Results for the twelve months ended 31 December 2020
28-Oct-20
Trading update for the three months ended 30 September 2020
06-Aug-20
Interim Results for the 6 months ended 30 June 2020
Fact sheet
Learn moreLearn more about the medical solutions we offer
Learn moreContact the media team
Learn more